A recent meta-analysis of 55 studies showed that increased PD-L1 expression was overall a negative prognostic factor in patients with gynecological cancers; this was driven by a favorable OS for patients with ovarian cancer but a poor OS for patients with cervical cancer [100]. The gene discussed is CD274; the disease is cervical carcinoma.